The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants

American Journal of Transplantation

Volumn 8, Issue 2, 2008, Pages 277-287

  Streblow, D N ^b   Kreklywich, C N ^b   Andoh, T ^b   Moses, A V ^b   Dumortier, J ^b   Smith, P P ^b   Defilippis, V ^b   Fruh, K ^b   Nelson, J A ^b   Orloff, S L ^a,b,c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Accelerated rejection; Allograft vasculopathy; Angiogenesis; Arrays; Cardiac allograft rejection; Cardiac allograft vasculopathy; Chronic allograft rejection; Cyclosporine A; Cytomegalovirus (CMV); Cytomegalovirus infection; Transplant vascular sclerosis; Virus

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 2; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN CONVERTING ENZYME; EPHRIN A1; EPHRIN B1; EPHRIN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 14; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 5; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 5; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; KERATINOCYTE GROWTH FACTOR; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 2; SCATTER FACTOR; SOMATOMEDIN B; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE; UROKINASE RECEPTOR;

ANIMAL MODEL; ARTERIOSCLEROSIS; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENDOTHELIUM CELL; HEART GRAFT; MALE; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAVIOLET RADIATION; UPREGULATION; WOUND HEALING;

ANIMALS; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; GENOME; HEART TRANSPLANTATION; MALE; MATRIX METALLOPROTEINASES; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED F344; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS; WOUND HEALING;

EID: 38149088798     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.02062.x     Document Type: Article

References (31)

1. Melnick JL, Adam E, DeBakey ME. The link between CMV and atherosclerosis. Infect Med 1998 15 : 479 486.
2. Melnick JL, Petrie BL, Dreesman GR, Burek J, McCollum CH, DeBakey ME. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 1983 2 : 644 647.
3. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994 265 : 391 394.
4. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989 261 : 3561 3566.
5. Bruning JH, Persoons MCJ, Lemstrom KB, Stals FS, De Clereq E, Bruggeman CA. Enhancement of transplantation associated atherosclerosis by CMV, which can be prevented by antiviral therapy in the form of HPMPC. Transplant Int 1994 7 : 365 370.
6. Lemstrom K, Koskinen P, Krogerus L, Daemen M, Bruggeman CA, Hayry PJ. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection. Circulation 1995 92 : 2594 2604.
7. Lemstrom K, Persoons M, Bruggeman C, Ustinov J, Lautenschlager I, Hayry P. Cytomegalovirus infection enhances allograft arteriosclerosis in the rat. Transplant Proc 1993 25 : 1406 1407.
8. Orloff SL, Streblow DN, Soderberg-Naucler C, Yin Q, Kreklywich C, Corless CL et al. Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplants. Transplantation 2002 73 : 679 688.
9. Orloff SL, Yin Q, Coreless CL, Loomis CB, Rabkin JM, Wagner CR. A rat small bowel transplant model of chronic rejection: Histopathologic characteristics. Transplantation 1999 68 : 766 779.
10. Orloff SL, Yin Q, Corless CL, Orloff MS, Rabkin JM, Wagner CR. Tolerance induced by bone marrow chimerism prevents transplant vascular sclerosis in a rat model of small bowel transplant chronic rejection. Transplantation 2000 69 : 1295 1303.
11. Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant 1992 11 : S38 S44.
12. Cramer DV, Wu GD, Chapman FA, Cajulis E, Wang HK, Makowka L. Lymphocytic subsets and histopathologic changes associated with the development of heart transplant arteriosclerosis. J Heart Lung Transplant 1992 11 : 458 466.
13. Clinton SK, Libby P. Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med 1992 116 : 1292 1300.
14. Khurana R, Simons M. Insights from angiogenesis trials using fibroblast growth factor for advanced arteriosclerotic disease. Trends Cardiovasc Med 2003 13 : 116 122.
15. Shibata M, Suzuki H, Nakatani M, Koba S, Geshi E, Katagiri T et al. The involvement of vascular endothelial growth factor and flt-1 in the process of neointimal proliferation in pig coronary arteries following stent implantation. Histochem Cell Biol 2001 116 : 471 481.
16. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002 105 : 1135 1143.
17. Thuesen L, Kelbaek H, Klovgaard L, Helqvist S, Jorgensen E, Aljabbari S et al. Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: Subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT). Am Heart J 2006 152 : 1140 1145.
18. Suzuki S, Kamihata H, Hata T, Hayashi F, Miura A, Yoshinaga M et al. Success rate of implantation and mid-term outcomes of the sirolimus-eluting stent. Circ J 2007 71 : 15 19.
19. Oyabu J, Ueda Y, Ogasawara N, Okada K, Hirayama A, Kodama K. Angioscopic evaluation of neointima coverage: Sirolimus drug-eluting stent versus bare metal stent. Am Heart J 2006 152 : 1168 1174.
20. Kent D, Sheridan C. Choroidal neovascularization: A wound healing perspective. Mol Vis 2003 9 : 747 755.
21. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003 83 : 835 870.
22. Bruggeman CA. Cytomegalovirus and latancy: An overview. Virch Archiv B Cell Pathol 1993 64 : 325 333.
23. Bruggeman CA, Meijer H, Bosman F, van Boven CP. Biology of rat cytomegalovirus infection. Intervirology 1985 24 : 1 9.
24. Wentworth BB, French L. Plaque assay of cytomegalovirus strains of human origin. Proc Soc Exp Biol Med 1970 135 : 253 238.
25. Ono K, Lindsy ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969 57 : 225 229.
26. Streblow DN, Kreklywich C, Yin Q, De La Melena VT, Corless CL, Smith PA et al. Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants. J Virol 2003 77 : 2182 2194.
27. Streblow DN, Kreklywich CN, Smith P, Soule JL, Meyer C, Yin M et al. Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33. Am J Transplant 2005 5 : 436 442.
28. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003 9 : 653 660.
29. Hendrix M, Dormans PHJ, Kitseelar P, Bosman F, Bruggeman CA. The presence of CMV nucleic acids arterial walls of atherosclerotic and non-atherosclerotic patients. Am J Pathol 1989 134 : 1151 1157.
30. Das R, Philip S, Mahabeleshwar GH, Bulbule A, Kundu GC. Osteopontin: It's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression. IUBMB Life 2005 57 : 441 447.
31. Tuck AB, Hota C, Chambers AF. Osteopontin(OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent. Breast Cancer Res Treat 2001 70 : 197 204.